Conrad K A
Postgrad Med. 1984 Oct;76(5):71-3, 75-9. doi: 10.1080/00325481.1984.11698754.
With recent innovations in pharmaceutical technology, important new methods of drug delivery have joined established ones. Prolonged-release oral preparations can provide precisely controlled drug delivery, which permits less frequent dosage of drugs with a short elimination half-life and thus improves compliance. These preparations also can narrow fluctuations in plasma levels, which maximizes efficacy and minimizes toxicity. Sustained-release intraocular and transcutaneous preparations offer similar advantages. Infusion pumps provide predictable systemic delivery of drugs that cannot be given orally or transcutaneously. Further innovations can undoubtedly be expected. When the therapeutic alternatives include a prolonged-release preparation, its potential advantages should be weighed against its potential disadvantages. Although some of these preparations cost more, this disadvantage may be outweighed by potential advantages.
随着制药技术的最新创新,重要的新型给药方法已加入到现有的方法之中。缓释口服制剂能够实现精确控制的药物递送,对于消除半衰期短的药物而言,可减少给药频率,从而提高顺应性。这些制剂还能缩小血浆水平的波动,使疗效最大化并使毒性最小化。眼内和经皮缓释制剂也具有类似优势。输液泵能够实现可预测的全身性药物递送,这些药物无法通过口服或经皮给药。毫无疑问,未来还会有更多创新。当治疗选择包括缓释制剂时,应权衡其潜在优势与潜在劣势。尽管其中一些制剂成本更高,但这一劣势可能会被潜在优势所抵消。